Safety of coronary reactivity testing in women with no obstructive coronary artery disease: Results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study
Academic Article
Overview
MeSH Major
Coronary Angiography
Coronary Circulation
Coronary Vessels
Laser-Doppler Flowmetry
Microcirculation
Myocardial Ischemia
Vasodilator Agents
abstract
In women undergoing CRT for suspected MCD, contemporary testing carries a relatively low risk compared with the MACE rate in these women. These results support the use of CRT by experienced operators for establishing definitive diagnosis and assessing prognosis in this at-risk population. (Women's Ischemia Syndrome Evaluation [WISE]; NCT00832702).
